Výsledky vyhledávání - "Sonja Buschow"

Akademický článek

Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy

Autor: Yan Li, Patrick P C Boor, Dave Sprengers, Zhu Li, Sonja Buschow, Yisen Tang, Xiaomei Zhuang, Wanhua Feng, Guoying Zhou

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)

Immune checkpoint blockade, which enhances the reactivity of T cells to eliminate cancer cells, has emerged as a potent strategy in cancer therapy. Besides T cells, natural killer (NK) cells also play an indispensable role in tumor surveillance and d

Externí odkaz: https://doaj.org/article/2aac627a9ae64c3a9cf043c4532e4c52

Zobrazit plný text záznamu

Akademický článek

361 T cell receptor specific for tumor-restricted Ropporin-1 to treat triple negative breast cancer

Autor: John WM Martens, Reno Debets, Justine Michaux, Michal Bassani-Sternberg, Dian Kortleve, Sonja Buschow, Monique de Beijer, Dora Hammerl, Mandy Van Brakel, Rebecca Wijers, Daphne Roelofs, Madelon Badoux, Mieke A Timmermans, Anita C Liao, Erik Danen, Rachel JM Abbott

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)

Externí odkaz: https://doaj.org/article/33e6a6cb5cf54edbbedf27bd1eb6a7b0

Zobrazit plný text záznamu

Akademický článek

Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies

Autor: Luc J W van der Laan, Luc Magré, Monique M A Verstegen, Sonja Buschow, Maikel Peppelenbosch, Jyaysi Desai

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 5 (2023)

In the past decade, treatments targeting the immune system have revolutionized the cancer treatment field. Therapies such as immune checkpoint inhibitors have been approved as first-line treatment in a variety of solid tumors such as melanoma and non

Externí odkaz: https://doaj.org/article/e3abb4b4956942ebb00fa43fcb12ef3c

Zobrazit plný text záznamu